2013-2028 Report on Global Neurological Biomarkers Market by Player, Region, Type, Application and Sales Channel

Published: Jun, 2019 | Pages: 119 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Neurological Biomarkers market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Neurological Biomarkers from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Neurological Biomarkers market.

Leading players of Neurological Biomarkers including:
    Merck
    Quest Diagnostics
    Abbott
    Roche
    Illumina
    Bio-Rad Laboratories
    QIAGEN
    Myriad RBM
    Cisbio Bioassays
    Athena Diagnostics
    BGI
    Wuxi APP
    Aepodia
    Proteome Sciences
    Genewiz

Market split by Type, can be divided into:
    Proteomics
    Genomics
    Imaging
    Bioinformatics
    Others

Market split by Application, can be divided into:
    Diagnostics
    Drug Discovery
    Personalized Medicine
    Others

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 Neurological Biomarkers Market Overview
    1.1 Neurological Biomarkers Definition
    1.2 Global Neurological Biomarkers Market Size Status and Outlook (2013-2028)
    1.3 Global Neurological Biomarkers Market Size Comparison by Region (2013-2028)
    1.4 Global Neurological Biomarkers Market Size Comparison by Type (2013-2028)
    1.5 Global Neurological Biomarkers Market Size Comparison by Application (2013-2028)
    1.6 Global Neurological Biomarkers Market Size Comparison by Sales Channel (2013-2028)
    1.7 Neurological Biomarkers Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Neurological Biomarkers Market Segment Analysis by Player
    2.1 Global Neurological Biomarkers Sales and Market Share by Player (2016-2018)
    2.2 Global Neurological Biomarkers Revenue and Market Share by Player (2016-2018)
    2.3 Global Neurological Biomarkers Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Neurological Biomarkers Market Segment Analysis by Type
    3.1 Global Neurological Biomarkers Market by Type
        3.1.1 Proteomics
        3.1.2 Genomics
        3.1.3 Imaging
        3.1.4 Bioinformatics
        3.1.5 Others
    3.2 Global Neurological Biomarkers Sales and Market Share by Type (2013-2018)
    3.3 Global Neurological Biomarkers Revenue and Market Share by Type (2013-2018)
    3.4 Global Neurological Biomarkers Average Price by Type (2013-2018)
    3.5 Leading Players of Neurological Biomarkers by Type in 2018
    3.6 Conclusion of Segment by Type
Chapter 4 Neurological Biomarkers Market Segment Analysis by Application
    4.1 Global Neurological Biomarkers Market by Application
        4.1.1 Diagnostics
        4.1.2 Drug Discovery
        4.1.3 Personalized Medicine
        4.1.4 Others
    4.2 Global Neurological Biomarkers Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Neurological Biomarkers by Application in 2018
    4.4 Conclusion of Segment by Application
Chapter 5 Neurological Biomarkers Market Segment Analysis by Sales Channel
    5.1 Global Neurological Biomarkers Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Neurological Biomarkers Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Neurological Biomarkers by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Neurological Biomarkers Market Segment Analysis by Region
    6.1 Global Neurological Biomarkers Market Size and CAGR by Region (2013-2028)
    6.2 Global Neurological Biomarkers Sales and Market Share by Region (2013-2018)
    6.3 Global Neurological Biomarkers Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Neurological Biomarkers Market Share by Type
        6.4.3 North America Neurological Biomarkers Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Neurological Biomarkers Market Share by Type
        6.5.3 Europe Neurological Biomarkers Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Neurological Biomarkers Market Share by Type
        6.6.3 Asia-Pacific Neurological Biomarkers Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Neurological Biomarkers Market Share by Type
        6.7.3 South America Neurological Biomarkers Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Neurological Biomarkers Market Share by Type
        6.8.3 Middle East & Africa Neurological Biomarkers Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Neurological Biomarkers Players
    7.1 Merck
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Quest Diagnostics
    7.3 Abbott
    7.4 Roche
    7.5 Illumina
    7.6 Bio-Rad Laboratories
    7.7 QIAGEN
    7.8 Myriad RBM
    7.9 Cisbio Bioassays
    7.10 Athena Diagnostics
    7.11 BGI
    7.12 Wuxi APP
    7.13 Aepodia
    7.14 Proteome Sciences
    7.15 Genewiz
Chapter 8 Upstream and Downstream Analysis of Neurological Biomarkers
    8.1 Industrial Chain of Neurological Biomarkers
    8.2 Upstream of Neurological Biomarkers
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Neurological Biomarkers
        8.3.1 Leading Distributors/Dealers of Neurological Biomarkers
        8.3.2 Leading Consumers of Neurological Biomarkers
Chapter 9 Development Trend of Neurological Biomarkers (2019-2028)
    9.1 Global Neurological Biomarkers Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Neurological Biomarkers Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Neurological Biomarkers Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Neurological Biomarkers Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Neurological Biomarkers Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure Neurological Biomarkers Example
    Figure Global Neurological Biomarkers Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Neurological Biomarkers Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Neurological Biomarkers Sales Comparison by Type (2013-2028)
    Figure Global Neurological Biomarkers Sales Comparison by Application (2013-2028)
    Figure Global Neurological Biomarkers Sales Comparison by Sales Channel (2013-2028)
    Table Global Neurological Biomarkers Sales by Player (2016-2018)
    Table Global Neurological Biomarkers Sales Market Share by Player (2016-2018)
    Figure Global Neurological Biomarkers Sales Market Share by Player in 2018
    Table Global Neurological Biomarkers Revenue (Million $) by Player (2016-2018)
    Table Global Neurological Biomarkers Revenue Market Share by Player (2016-2018)
    Figure Global Neurological Biomarkers Revenue Market Share by Player in 2018
    Table Global Neurological Biomarkers Average Price by Player (2016-2018)
    Figure Global Neurological Biomarkers Average Price by Player in 2018
    Figure Global Neurological Biomarkers Players Competition Situation - Top 5 Players' Revenue Market Share in 2016
    Figure Global Neurological Biomarkers Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Proteomics
    Figure Global Proteomics Sales and Growth Rate (2013-2018)
    Figure Example of Genomics
    Figure Global Genomics Sales and Growth Rate (2013-2018)
    Figure Example of Imaging
    Figure Global Imaging Sales and Growth Rate (2013-2018)
    Figure Example of Bioinformatics
    Figure Global Bioinformatics Sales and Growth Rate (2013-2018)
    Figure Example of Others
    Figure Global Others Sales and Growth Rate (2013-2018)
    Table Global Neurological Biomarkers Sales by Type (2013-2018)
    Table Global Neurological Biomarkers Sales Market Share by Type (2013-2018)
    Figure Global Neurological Biomarkers Sales Market Share by Type in 2018
    Table Global Neurological Biomarkers Revenue (Million $) by Type (2013-2018)
    Table Global Neurological Biomarkers Revenue Market Share by Type (2013-2018)
    Figure Global Neurological Biomarkers Revenue Market Share by Type in 2018
    Table Global Neurological Biomarkers Average Price by Type (2013-2018)
    Figure Global Neurological Biomarkers Average Price by Type in 2018
    Table Leading Players of Neurological Biomarkers by Type in 2018
    Figure Example of Diagnostics
    Figure Global Neurological Biomarkers for Diagnostics Sales and Growth Rate (2013-2018)
    Figure Example of Drug Discovery
    Figure Global Neurological Biomarkers for Drug Discovery Sales and Growth Rate (2013-2018)
    Figure Example of Personalized Medicine
    Figure Global Neurological Biomarkers for Personalized Medicine Sales and Growth Rate (2013-2018)
    Figure Example of Others
    Figure Global Neurological Biomarkers for Others Sales and Growth Rate (2013-2018)
    Table Global Neurological Biomarkers Sales by Application (2013-2018)
    Table Global Neurological Biomarkers Sales Market Share by Application (2013-2018)
    Figure Global Neurological Biomarkers Sales Market Share by Application in 2018
    Table Leading Consumers of Neurological Biomarkers by Application in 2018
    Figure Example of Direct Channel
    Figure Global Neurological Biomarkers for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Neurological Biomarkers for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Neurological Biomarkers Sales by Sales Channel (2013-2018)
    Table Global Neurological Biomarkers Sales Market Share by Sales Channel (2013-2018)
    Figure Global Neurological Biomarkers Sales Market Share by Sales Channel in 2018
    Table Leading Distributors/Dealers of Neurological Biomarkers by Sales Channel in 2018
    Table Global Neurological Biomarkers Market Size and CAGR by Region (2013-2028)
    Table Global Neurological Biomarkers Sales by Region (2013-2018)
    Table Global Neurological Biomarkers Sales Market Share by Region (2013-2018)
    Figure Global Neurological Biomarkers Sales Market Share by Region in 2018
    Table Global Neurological Biomarkers Revenue (Million $) by Region (2013-2018)
    Table Global Neurological Biomarkers Revenue Market Share by Region (2013-2018)
    Figure Global Neurological Biomarkers Revenue Market Share by Region in 2018
    Table North America Neurological Biomarkers Sales by Country (2013-2018)
    Figure North America Neurological Biomarkers Sales Market Share by Country (2013-2018)
    Table North America Neurological Biomarkers Revenue by Country (2013-2018)
    Figure North America Neurological Biomarkers Revenue Market Share by Country (2013-2018)
    Figure North America Neurological Biomarkers Sales Market Share by Type in 2018
    Figure North America Neurological Biomarkers Sales Market Share by Application in 2018
    Figure United States Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure United States Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Canada Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Mexico Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Neurological Biomarkers Sales by Country (2013-2018)
    Figure Europe Neurological Biomarkers Sales Market Share by Country (2013-2018)
    Table Europe Neurological Biomarkers Revenue by Country (2013-2018)
    Figure Europe Neurological Biomarkers Revenue Market Share by Country (2013-2018)
    Figure Europe Neurological Biomarkers Sales Market Share by Type in 2018
    Figure Europe Neurological Biomarkers Sales Market Share by Application in 2018
    Figure Germany Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Germany Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure UK Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure France Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Italy Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Russia Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Spain Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Neurological Biomarkers Sales by Country (2013-2018)
    Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Neurological Biomarkers Revenue by Country (2013-2018)
    Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Type in 2018
    Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Application in 2018
    Figure China Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure China Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Japan Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Korea Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure India Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Australia Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Neurological Biomarkers Sales by Country (2013-2018)
    Figure South America Neurological Biomarkers Sales Market Share by Country (2013-2018)
    Table South America Neurological Biomarkers Revenue by Country (2013-2018)
    Figure South America Neurological Biomarkers Revenue Market Share by Country (2013-2018)
    Figure South America Neurological Biomarkers Sales Market Share by Type in 2018
    Figure South America Neurological Biomarkers Sales Market Share by Application in 2018
    Figure Brazil Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Brazil Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Argentina Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Colombia Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Chile Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Neurological Biomarkers Sales by Country (2013-2018)
    Figure Middle East & Africa Neurological Biomarkers Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Neurological Biomarkers Revenue by Country (2013-2018)
    Figure Middle East & Africa Neurological Biomarkers Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Neurological Biomarkers Sales Market Share by Type in 2018
    Figure Middle East & Africa Neurological Biomarkers Sales Market Share by Application in 2018
    Figure Egypt Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Egypt Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure South Africa Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Neurological Biomarkers Sales and Growth Rate (2013-2018)
    Figure Nigeria Neurological Biomarkers Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Merck
    Table Neurological Biomarkers Introduction of Merck
    Table Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share of Merck (2016-2018)
    Table Industrial Chain of Neurological Biomarkers
    Table Manufacturing Cost Structure of Neurological Biomarkers
    Table General Manufacturing Process of Neurological Biomarkers
    Table Leading Distributors/Dealers of Neurological Biomarkers
    Table Leading Consumers of Neurological Biomarkers
    Figure Global Neurological Biomarkers Sales and Growth Rate Forecast (2019-2028)
    Figure Global Neurological Biomarkers Revenue and Growth Rate Forecast (2019-2028)
    Table Global Neurological Biomarkers Market Size and CAGR Forecast by Region (2019-2028)
    Table Global Neurological Biomarkers Market Size and CAGR Forecast by Type (2019-2028)
    Table Global Neurological Biomarkers Market Size and CAGR Forecast by Application (2019-2028)
    Table Global Neurological Biomarkers Market Size and CAGR Forecast by Sales Channel (2019-2028)